Sandy Spring Bank Scynexis Inc Transaction History
Sandy Spring Bank
- $2.42 Billion
- Q4 2024
A detailed history of Sandy Spring Bank transactions in Scynexis Inc stock. As of the latest transaction made, Sandy Spring Bank holds 4,000 shares of SCYX stock, worth $4,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$4,640
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SCYX
# of Institutions
52Shares Held
12.8MCall Options Held
10.3KPut Options Held
2.6K-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$3.36 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$2.59 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.93 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$1.43 Million0.16% of portfolio
-
Amh Equity LTD626KShares$726,2200.79% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $37.9M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...